Novel Influenza A Virus Biosafety Guidance Update

On June 6, 2024, the U.S. Centers for Disease Control and Prevention (CDC) updated the laboratory biosafety guidelines for handling and processing specimens associated with Novel Influenza A viruses webpage to include additional information about risk assessment and mitigation, diagnostic testing, and decontamination and waste management. The risk posed by Novel Influenza A viruses to the public…

CDC Enhanced Summer 2024 Influenza Surveillance Strategy

On June 6, 2024, the Administrator of the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) announced a temporary exemption for H5 avian influenza viruses from the requirements of the select agent and toxin regulations for a period of three years utilizing the exemption authority under 9 C.F.R. §121.5(f). This exemption replaces all…